Two Sigma Investments, LP Oncternal Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.29 - $0.48 $1,971 - $3,264	-6,800 Reduced 8.35%	74,681 $22,000
Q2 2023 Aug 14, 2023	SELL	$0.28 - $0.79 $0 - $2	-3 Reduced -0.0%	81,481 $27,000
Q1 2023 May 15, 2023	SELL	$0.63 - $1.3 $58,940 - $121,622	-93,556 Reduced 53.45%	81,484 $64,000
Q4 2022 Feb 14, 2023	SELL	$0.86 - $22.2 $155,835 - $4.02 Million	-181,204 Reduced 50.87%	175,040 $175,000
Q3 2022 Nov 14, 2022	BUY	$0.83 - $17.8 $170,408 - $3.65 Million	205,312 Added 136.03%	356,244 $318,000
Q2 2022 Aug 15, 2022	SELL	$0.7 - $1.56 $28,057 - $62,527	-40,082 Reduced 20.98%	150,932 $168,000
Q1 2022 May 16, 2022	BUY	$1.37 - $2.43 $75,562 - $134,026	55,155 Added 40.6%	191,014 $266,000
Q4 2021 Feb 14, 2022	SELL	$2.27 - $4.39 $718,709 - $1.39 Million	-316,612 Reduced 69.97%	135,859 $308,000
Q3 2021 Nov 15, 2021	SELL	$3.37 - $4.76 $337,913 - $477,289	-100,271 Reduced 18.14%	452,471 $1.89 Million
Q2 2021 Aug 16, 2021	BUY	$4.75 - $9.39 $2.1 Million - $4.15 Million	441,781 Added 398.14%	552,742 $2.63 Million
Q1 2021 May 17, 2021	SELL	$4.59 - $9.04 $340,265 - $670,153	-74,132 Reduced 40.05%	110,961 $923,000
Q4 2020 Feb 16, 2021	BUY	$1.51 - $6.3 $279,490 - $1.17 Million	185,093 New	185,093 $907,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $62.7M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.